Levy Emmanuelle, Traicu Alexandru, Iyer Srividya, Malla Ashok, Joober Ridha
Assistant Professor, Department of Psychiatry, McGill University, Montreal, Quebec; Psychiatrist, Douglas Mental Health University Institute, Montreal, Quebec.
Psychiatrist, Douglas Mental Health University Institute, Montreal, Quebec.
Can J Psychiatry. 2015 Mar;60(3 Suppl 2):S48-52.
Psychotic disorders (PDs) and attention-deficit hyperactivity disorder (ADHD) are frequently comorbid. Clinicians are often reticent to treat ADHD in patients with psychosis, fearing that psychostimulants will worsen psychotic symptoms. Advances in neurobiology have challenged the simplistic dichotomy where PD is considered a disorder of high dopamine (DA), treated by DA antagonists, and ADHD a disorder of low DA, treated by DA agonists. In our paper, we review the literature on comorbid ADHD and psychosis. Treating ADHD with psychostimulants may be considered in patients with PD who have been stabilized with antipsychotics (APs). Not treating ADHD may have consequences because ADHD may predispose patients to drug abuse, which further increases the risk of PD. Nevertheless, more systematic studies are needed as there remains some uncertainty on the combined use of APs and psychostimulants in comorbid PD and ADHD.
精神障碍(PDs)和注意力缺陷多动障碍(ADHD)常常共病。临床医生通常不愿治疗患有精神病的ADHD患者,担心精神兴奋剂会加重精神病症状。神经生物学的进展对这种简单的二分法提出了挑战,即PD被认为是一种高多巴胺(DA)紊乱,用DA拮抗剂治疗,而ADHD是一种低DA紊乱,用DA激动剂治疗。在我们的论文中,我们回顾了关于共病ADHD和精神病的文献。对于已用抗精神病药物(APs)稳定病情的PD患者,可以考虑用精神兴奋剂治疗ADHD。不治疗ADHD可能会产生后果,因为ADHD可能使患者易患药物滥用,这进一步增加了患PD的风险。然而,由于在共病PD和ADHD中联合使用APs和精神兴奋剂仍存在一些不确定性,因此需要进行更系统的研究。